Literature DB >> 12839282

Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura.

O Erdoğan1, A Oner, A Aydin, A Işimer, G Demircin, M Bülbül.   

Abstract

AIM: To evaluate the role of reactive oxygen molecules (ROMs) in the pathogenesis of Henoch-Schönlein purpura and the effect of vitamin E on oxidative damage. ROMs have been suggested to contribute in many pathological conditions including renal diseases and vasculitis.
METHODS: The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) as antioxidant enzymes were measured, and the level of malondialdehyde (MDA) as an indicator of lipid peroxidation in 27 children with Henoch-Schönlein purpura at the onset of the disease and during the remission period. The results of this study were compared with those of 11 healthy children studied as a control group.
RESULTS: With regard to all the oxidative damage parameters such as SOD, GSH-Px and MDA, significant differences were detected between the patients and the control group in both the acute and remission periods. But no such differences were detected between patients with and those without renal involvement. In 15 patients receiving vitamin E treatment, oxidative damage parameters and clinical course showed no improvement despite significant increases in plasma vitamin E levels.
CONCLUSION: Oxidative damage and lipid peroxidation may play an important part in the pathogenesis of Henoch-Schönlein purpura but vitamin E given after initiation of lipid peroxidation, which is the last phase of cellular damage, is of no use in breaking down the oxidative chain reactions that have already been triggered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839282     DOI: 10.1080/08035350310011461

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

Review 1.  Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic review.

Authors:  Marco Zaffanello; Milena Brugnara; Massimo Franchini; Vassilios Fanos
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

2.  Serum and urine nitric oxide levels in children with Henoch-Schonlein purpura during activity and remission: a study from North India.

Authors:  Vikas Mahajan; Surjit Singh; Madhu Khullar; Ranjana W Minz
Journal:  Rheumatol Int       Date:  2008-11-29       Impact factor: 2.631

3.  Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Aşkin Hekimoğlu; Halil Kocamaz; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Pediatr Nephrol       Date:  2007-04-03       Impact factor: 3.714

4.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

5.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

6.  Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Halil Kocamaz; Aşkin Hekimoğlu; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

7.  Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura.

Authors:  Dolunay Gurses; Nusret Parlaz; Melek Bor-Kucukatay; Vural Kucukatay; Gulten Erken
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

8.  Efficacy of montelukast for the treatment of pediatric allergic purpura.

Authors:  Li-Ping Bai; Jing Yu; Ya-Xin Sun; Jiu-Mei Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

9.  Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.

Authors:  Jianjiang Zhang; Huiqin Zeng; Na Wang; Xiyan Tian; Wenjie Dou; Peipei Shi
Journal:  Eur J Pediatr       Date:  2015-07-30       Impact factor: 3.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.